We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.
3g9e
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
'''Unreleased structure''' | '''Unreleased structure''' | ||
| - | The entry 3g9e is ON HOLD | + | The entry 3g9e is ON HOLD until Paper Publication |
Authors: Benardeau, A. | Authors: Benardeau, A. | ||
| Line 7: | Line 7: | ||
Description: Aleglitaar. a new. potent, and balanced dual ppara/g agonist for the treatment of type II diabetes | Description: Aleglitaar. a new. potent, and balanced dual ppara/g agonist for the treatment of type II diabetes | ||
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Mar | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Mar 25 12:13:48 2009'' |
Revision as of 10:13, 25 March 2009
Unreleased structure
The entry 3g9e is ON HOLD until Paper Publication
Authors: Benardeau, A.
Description: Aleglitaar. a new. potent, and balanced dual ppara/g agonist for the treatment of type II diabetes
Page seeded by OCA on Wed Mar 25 12:13:48 2009
